Home > Insider Trading > Filing (0001317757-10-000019)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	In Vitro & In Vivo Diagnostic Substances (2835)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1465314	Ricardo Zayas	100 Hayden Avenue Lexington MA 02421	Svp, Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-06-08	2,500	$0.00	12,087	No	4	C	Direct
Common Stock	Disposition	2010-06-08	300	$32.46	11,787	No	4	S	Direct
Common Stock	Disposition	2010-06-08	100	$32.46	11,687	No	4	S	Direct
Common Stock	Disposition	2010-06-08	400	$32.47	11,287	No	4	S	Direct
Common Stock	Disposition	2010-06-09	295	$32.46	10,992	No	4	S	Direct
Common Stock	Disposition	2010-06-09	100	$32.45	10,892	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Acquisiton	2010-06-08	2,500	$0.00	2,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,500			No	4	C	Direct

Footnotes

Not applicable.
Each restricted stock unit represents a contingent right to receive one unit of the Issuer's common stock.
Grant of restricted stock unit pursuant to AMAG Pharmaceuticals, Inc.'s Amended and Restated 2007 Equity Incentive Plan. The grant is exercisable in four equal installments. The first installment vested on June 8, 2010, the first anniversary of the grant. The remaining installments will vest on June 8, 2011, June 8, 2012, June 8, 2013, respectively.